PHAR Latest Press Releases, Pharming Group N.V. Corporate News

Releases

9.33

-8.26%

-0.84

All
Financials
Insiders

6-K | Pharming Group N.V.(0001828316)
Apr 08,2024 06:16
6-K | Pharming Group N.V.(0001828316)
Apr 04,2024 08:21
20-F | Pharming Group N.V.(0001828316)
Apr 04,2024 08:12
6-K | Pharming Group N.V.(0001828316)
Mar 14,2024 06:34
SC 13G | Pharming Group N.V.(0001828316)
Feb 14,2024 07:04
6-K | Pharming Group N.V.(0001828316)
Jan 08,2024 09:25
6-K | Pharming Group N.V.(0001828316)
Dec 15,2023 06:43
6-K | Pharming Group N.V.(0001828316)
Nov 13,2023 10:03
6-K | Pharming Group N.V.(0001828316)
Oct 26,2023 09:26
6-K | Pharming Group N.V.(0001828316)
Sep 25,2023 10:21
6-K | Pharming Group N.V.(0001828316)
Aug 14,2023 08:32
6-K | Pharming Group N.V.(0001828316)
Aug 09,2023 11:25
6-K | Pharming Group N.V.(0001828316)
Aug 03,2023 11:10
6-K | Pharming Group N.V.(0001828316)
Jul 18,2023 06:41
6-K | Pharming Group N.V.(0001828316)
Jun 01,2023 06:15
6-K | Pharming Group N.V.(0001828316)
May 19,2023 06:58
6-K | Pharming Group N.V.(0001828316)
May 11,2023 06:08
6-K | Pharming Group N.V.(0001828316)
Apr 11,2023 08:58
20-F | Pharming Group N.V.(0001828316)
Apr 05,2023 07:02
6-K | Pharming Group N.V.(0001828316)
Apr 05,2023 06:32
6-K | Pharming Group N.V.(0001828316)
Mar 27,2023 13:52
6-K | Pharming Group N.V.(0001828316)
Mar 16,2023 10:39
6-K | Pharming Group N.V.(0001828316)
Mar 13,2023 07:34
6-K | Pharming Group N.V.(0001828316)
Mar 13,2023 07:02
6-K | Pharming Group N.V.(0001828316)
Feb 21,2023 09:43
6-K | Pharming Group N.V.(0001828316)
Feb 17,2023 10:42
6-K | Pharming Group N.V.(0001828316)
Oct 27,2022 06:35
6-K | Pharming Group N.V.(0001828316)
Aug 04,2022 06:12
6-K | Pharming Group N.V.(0001828316)
Aug 02,2022 06:16
6-K | Pharming Group N.V.(0001828316)
Aug 01,2022 06:14
6-K | Pharming Group N.V.(0001828316)
Jun 02,2022 21:59
6-K | Pharming Group N.V.(0001828316)
May 18,2022 12:58
6-K | Pharming Group N.V. (0001828316)
May 12,2022 06:37
6-K | Pharming Group N.V. (0001828316)
May 05,2022 06:44
6-K | Pharming Group N.V. (0001828316)
Apr 26,2022 07:06
6-K | Pharming Group N.V. (0001828316)
Apr 22,2022 06:46
6-K | Pharming Group N.V. (0001828316)
Apr 06,2022 16:09
20-F | Pharming Group N.V. (0001828316)
Apr 06,2022 16:07
6-K | Pharming Group N.V.(0001828316)
Apr 01,2022 06:34
6-K | Pharming Group N.V. (0001828316)
Mar 17,2022 06:42
6-K | Pharming Group N.V. (0001828316)
Mar 08,2022 06:09
6-K | Pharming Group N.V. (0001828316)
Feb 02,2022 06:36
6-K | Pharming Group N.V. (0001828316)
Jan 06,2022 07:01
6-K | Pharming Group N.V. (0001828316)
Jan 04,2022 07:02
S-8 | Pharming Group N.V. (0001828316)
Oct 28,2021 16:17
6-K | Pharming Group N.V. (0001828316)
Oct 28,2021 07:03
6-K | Pharming Group N.V. (0001828316)
Oct 22,2021 07:01
6-K | Pharming Group N.V. (0001828316)
Sep 14,2021 08:59
6-K/A | Pharming Group N.V. (0001828316)
Aug 09,2021 16:04
6-K Pharming Group N.V. (0001828316) (Filer)
Aug 05,2021 07:00

Webull provides the latest Pharming Group N.V. (PHAR) stock and general news. This information may help you make smarter investment decisions.

About PHAR

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.